LKT Labs

Biochemicals for Life Science Research

G250.A2 Peptide

G250.A2 Peptide

Product ID G0000
Cas No.
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $89.70 In stock
2 mg $151.30 In stock
5 mg $269.90 In stock
Bulk Quote

Quicklinks

Description

G250.A2 is an HLA-A2-restricted peptide epitope of hypoxia-dependent carbonic anhydrase G250 that is recognized by T cells.

Product Info

Purity

≥95%
Formula

C45H72N14O12
Formula Wt.

1001.16

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

Info Sheet

G0000 Info Sheet PDF

References

Socie G, Blazar BR. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Elsevier, 2012. Web.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F4782

    Fludarabine Phosphate

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%
  • S0278

    Satraplatin

    Pt-based DNA cross-linker.

    ≥98%
  • L589940

    LOXO-101

    Inhibitor of tropomyosin kinase receptors TRKA,...

    ≥99%
  • L5862

    Lopinavir

    HIV protease inhibitor, SERCA inhibitor.

    ≥98%
  • C4757

    Clozapine

    M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...

    ≥97%
  • R0212

    Radicicol

    Benzoquinone ansamycin; topoisomerase VI-B, HSP...

    ≥96%
  • D183734

    7-O-Desmethyl Rapamycin

    Rapamycin impurity

    ≥85%
  • T3324

    Tigecycline

    Glycylcycline; protein synthesis inhibitor.

    ≥98%
  • A081014

    Acalabrutinib

    Inhibitor of Bruton’s tyrosine kinase (BTK).<...

    ≥99%
  • D1722

    Defactinib

    FAK inhibitor.

    ≥98%
  • R3321

    Rifaximin

    Rifampicin derivative; DNA-dependent RNA polyme...

    ≥98%
  • F3206

    Fibrinolysis Inhibiting Factor

    Peptide; fibrinolysis inhibitor.

    ≥98%
  • T2792

    TGX-221

    p110β PI3K inhibitor.
  • N3278

    7-Nitroindazole

    nNOS inhibitor.

    ≥98%
  • A0778

    ABT-737

    BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.

    ≥98%
  • J0240

    JAK2 Inhibitor V

    JAK2 inhibitor.

    ≥98%
  • G1209

    GDC-0980

    PI3K and mTOR inhibitor.

    ≥98%
  • H9862

    Hypothemycin

    Polyketide found in Setophoma.

    ≥96%
  • U6802

    Urapidil Hydrochloride

    5-HT1A agonist, α1-adrenergic antagonist.

    ≥98%
  • P1760

    Peptide T

    Peptide fragment of HIV-1 gp120.

    ≥98%